CompaniesNanoBio

NanoBio

defunct

About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

80

By Status

UNKNOWN: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2019

2020

2021

2022

2023

Today

Hover over trial bars to see details

Recent Trials

NCT04465981Lead Sponsor

Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients

80 participants

Started: Jul 3, 2020 · Completed: Dec 31, 2022

Funding History (8)

D

Feb 12, 2024

D

Oct 14, 2022

D

Apr 8, 2020

D

Sep 5, 2019

D

May 30, 2018

D

Feb 15, 2017

D

Feb 4, 2016

D/A

May 29, 2009